https://doi.org/10.4081/vl.2026.14852
Where has pathophysiology gone in the era of evidence-based medicine? In Memoriam of Giuseppe Maria Andreozzi (1945-2026)
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 16 March 2026
Professor Giuseppe Maria Andreozzi passed away on January 10, 2026.
Born on October 13, 1945, he was a distinguished Italian physician and an internationally respected researcher in the field of Vascular Medicine.
He served as Professor of Angiology at the University of Catania until 1997, after which he moved to the University of Padua, where he became Chief of the Angiology Unit.
Professor Andreozzi was a past President of the Italian Society of Angiology and Vascular Medicine (SIAPAV) and an active member of the most important international scientific societies of vascular medicine.
Throughout his career, he authored more than 400 scientific publications on Angiology.
Downloads
1. Andreozzi GM, Bignamini AA, Davì G, et al. SURVET Study Investigators. Sulodexide for the prevention of recurrent venous thromboembolism: the Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation 2015;132:1891-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016930
2. Andreozzi GM. Propionyl l-carnitine: intermittent claudication and peripheral arterial disease. Expert Opin Pharmacother 2009;10:2697-707. DOI: https://doi.org/10.1517/14656560903215871
3. Zamboni P, Lanzara S, Mascoli F, et al. Inflammation in venous disease. Int Angiol 2008;27:361-9.
4. Andreozzi GM, Martini R, Cordova R, et al. Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease? Int Angiol 2007;26:245-52.
5. Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int J Mol Sci 2022;23:12906. DOI: https://doi.org/10.3390/ijms232112906
6. Singh AV, Gemmati D, Kanase A, et al. Nanobiomaterials for vascular biology and wound management: a review. Veins and Lymphatics 2018;7:7196. DOI: https://doi.org/10.4081/vl.2018.7196
7. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22. DOI: https://doi.org/10.1016/S0140-6736(02)09327-3
8. Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol 2010;106:204-9. DOI: https://doi.org/10.1016/j.amjcard.2010.03.018
9. Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation 2018;137:338-50. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.032235
10. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420-5. DOI: https://doi.org/10.1001/jama.1992.03490170092032
11. Woods NN. Science is fundamental: the role of biomedical knowledge in clinical reasoning. Med Educ 2007;41:1173-7. DOI: https://doi.org/10.1111/j.1365-2923.2007.02911.x
12. Bluhm R, Tonelli M. Knowledge of mechanism and pathophysiologic reasoning. In: On What Evidence? Making the Case in Medical Decision-Making. Oxford Academic; New York, USA; 2025. Available from: https://doi.org/10.1093/9780197503867.003.0004 DOI: https://doi.org/10.1093/9780197503867.003.0004
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
